What serious adverse reactions happened during this study?
No serious adverse reactions happened during this study.

What adverse reactions happened during this study?
The most common adverse reaction was a headache.

The adverse reactions that happened during the study are as follows:

Acalabrutinib tablet:
- Headache: 6.2% (4)
- Sluggishness: 0.0% (0)
- Diarrhea: 1.5% (1)
- Dizziness: 1.5% (1)

Acalabrutinib capsule:
- Headache: 0.0% (0)
- Sluggishness: 1.6% (1)
- Diarrhea: 0.0% (0)
- Dizziness: 0.0% (0)

This study helped researchers learn more about how acalabrutinib acts in the blood in healthy participants when taken in different ways.

Researchers look at the results of many studies to decide which treatments work best and are safest. This summary shows only the main results from this one study. Other studies may provide new information or different results.

Further clinical studies with acalabrutinib are planned.